Insights: Healthcare

DMEPOS Moratorium

CMS has announced a six-month nationwide moratorium on the enrollment of new Medicare and Medicaid DMEPOS suppliers.

Medicaid Payments (MN)

CMS has deferred payment of ~$260m in Medicaid federal matching dollars to the state of Minnesota (MN). The payments stem from claims submitted by the state in Q4 2025, specifically for personal care services (PCS), home- and community-based services (HCBS), and unspecified “other practitioner services.”

FDA Approval Process (Rare Disease Drugs)

The FDA has issued draft guidance outlining its “Plausible Mechanism Framework” for the development of therapeutics for rare diseases. Stakeholder comments on the draft guidance are due by April 27, 2026.

Medicare Advantage

Lobbying around the PY27 MA Advance Notice – the comment period for which closed on Wednesday (2/25) – is intensifying ahead of finalization (which must occur by April 6). Industry advocates (represented primarily by the Better Medicare Alliance) have been circulating a report suggesting the proposed rate update would result in increased senior...

CMMI ACCESS Model (Health Tech)

The CMS Innovation Center (CMMI) has released guidance providing more granular details on key parameters of its “Advancing Chronic Care with Effective, Scalable Solutions” (ACCESS) Model.

BIOSECURE Act (Wuxi)

The Pentagon last Friday updated its list of Chinese military companies to include biotechnology firm Wuxi but retracted that update within minutes. Under the recently passed Biosecure Act, any firm on the Pentagon’s list of Chinese military companies would be banned from contracting with the federal government. The Pentagon is still obligated...